Advertisement

Topics

Independent research may change the immunotherapy game

05:59 EDT 17 Aug 2017 | Pharmafile

Immunotherapy treatments that focus on the PD-L1 protein have become some of the most exciting to emerge in cancer treatment. Treatments are so successful, in certain patients, that they’ve become an extremely lucrative market – so much so that AstraZeneca’s fortunate were sunk on the poor result of one combination trial with its own PD-L1 inhibitor, Imfinzi.

read more

Original Article: Independent research may change the immunotherapy game

NEXT ARTICLE

More From BioPortfolio on "Independent research may change the immunotherapy game"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...